PH-3861

N/A

Report date: 2022/05/10 11:42:40
NME

Base Information

Drug NamePH-3861
Drug Alias NamePH3861
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionProgrammed cell death protein 1 blockersRNA interference
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhio Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesPhio Pharmaceuticals Corp
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A